Drug Type AAV based gene therapy |
Synonyms- |
Target |
Mechanism CD40 agonists(Tumor necrosis factor receptor superfamily member 5 agonists), CXCL9 agonists(C-X-C motif chemokine ligand 9 agonists), IL-15 agonists(Interleukin-15 agonists) |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Pancreatic Cancer | Preclinical | GB | 05 Nov 2024 |